Gene · 53947
Papers2,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss-of-function Gαs rare disease variants exert mutation-specific effects on GPCR signaling. | Sci Signal | 2025 | 40392940 | PubTator, text mining | PubMed |
| ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment'. | Eur Heart J Suppl | 2025 | 40385469 | PubTator, text mining | PubMed |
| ANMCO position paper: diagnosis and treatment of heart failure with preserved systolic function. | Eur Heart J Suppl | 2025 | 40385467 | PubTator, text mining | PubMed |
| "Real world" medical care of patients with Fabry disease by primary care physicians, internists or general practitioners. | Cardiovasc Diagn Ther | 2025 | 40385275 | PubTator, text mining | PubMed |
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| ɑ1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway. | Eur J Med Res | 2025 | 40312703 | PubTator, text mining | PubMed |
| Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. | Adv Sci (Weinh) | 2025 | 40285643 | PubTator, text mining | PubMed |
| Generation of a gene-corrected human isogenic iPSC line from a patient with Fabry disease carrying the GLA variant c.1069C>T using CRISPR/Cas9-mediated homology directed repair. | Stem Cell Res | 2025 | 40222082 | PubTator, text mining | PubMed |
| Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification. | Haematologica | 2025 | 40207710 | PubTator, text mining | PubMed |
| Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs. | Front Cardiovasc Med | 2025 | 40144933 | PubTator, text mining | PubMed |
| Fabry Disease and Its Different Phenotypes. | Arq Bras Cardiol | 2025 | 40136155 | PubTator, text mining | PubMed |
| Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA. | Int J Mol Sci | 2025 | 40076891 | PubTator, text mining | PubMed |
| Sex Differences in Circulating Inflammatory, Immune, and Tissue Growth Markers Associated with Fabry Disease-Related Cardiomyopathy. | Cells | 2025 | 40072051 | PubTator, text mining | PubMed |
| Early Potentially Irreversible Cardiac Damage in Fabry Disease Precedes Gb3 Inclusion Body Formation. | Can J Cardiol | 2025 | 40058731 | PubTator, text mining | PubMed |
| Homozygosity for a novel A4GALT allele resulting in the rare p phenotype in an Indian blood donor. | Vox Sang | 2025 | 39961283 | PubTator, text mining | PubMed |
| The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease. | BMC Nephrol | 2025 | 39948544 | PubTator, text mining | PubMed |
| Novel A4GALT Variants Cause Rare p Phenotype and Recurrent Pregnancy Loss in a Chinese Individual. | Am J Med Genet A | 2025 | 39907038 | PubTator, text mining | PubMed |
| The role of cardiovascular multimodality imaging in the evaluation of Anderson-Fabry disease: from early diagnosis to therapy monitoring. | Eur Heart J Cardiovasc Imaging | 2025 | 39903606 | PubTator, text mining | PubMed |
| Identification of Four New Mutations in the GLA Gene Associated with Anderson-Fabry Disease. | Int J Mol Sci | 2025 | 39859188 | PubTator, text mining | PubMed |
| Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial. | Clin Transl Med | 2025 | 39794302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53947/papers?page=5